ClinicalTrials.gg
Not yet recruitingNCT07848958Updated Nov 10, 2026

Fruit & Vegetable Consumption and Behavioral Determinants Among Health Profession Students

An observational study in Fruit and Vegetable Intake, University Students and College Students, sponsored by Loma Linda University. Not yet recruiting. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by Loma Linda University · Observational

How we know

Updated Nov 10, 2026Start date movedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
50
Ages
18 Years to 30 Years
Sex
All
01

Study summary

This is an ancillary study of National Clinical Trial (NCT) #06229262 (which was a clinical trial that examined the effect of a 12-week mango intervention in college/university students). The objective of this study is to characterize typical fruit and vegetable intake among healthcare profession students using existing dietary data the previously completed NCT#06229262 study, and to describe the associated behavioral context, including perceived barriers, facilitators, and fruit and vegetable-related self-efficacy, using survey data collected as part of this ancillary analysis.

02

Conditions studied

  • Fruit and Vegetable Intake
  • University Students
  • College Students
  • Self-Efficacy
  • Health Behavior Barriers and Facilitators

Browse trials for

03

In context

Health Behavior

970 studies on the registry are indexed under Health Behavior; 166 are open to participants now.

This study's planned enrollment of 50 is below the median of 220 across 132 observational studies indexed under Health Behavior.

Browse Health Behavior studies →

Lead sponsor

Loma Linda University is the lead sponsor of 306 studies on the registry; 46 are open to participants now.

Of its 29 completed or terminated interventional studies of FDA-regulated products, 23 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Loma Linda University health professions students or graduates who completed the NCT#:06229262 trial.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants that successfully completed the Immune and cognitive benefits of mango intake in young adults: A randomized trial (IRB#5230334) who consented to be contacted for future studies.
  • Participant who was enrolled in or was a recent graduate (within 2 years of graduation) from a health profession program at Loma Linda University during their participation in the parent study
  • Able to provide electronic to participate in the ancillary survey
  • Aged 18 - 30 years of age at the time of participation in the parent study

Exclusion criteria

Exclusion Criteria:

  • Participant who was in or was a recent graduate from a non-Loma Linda University Institution during the parent study
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
50 participants (estimated)
Patient registry
No

Groups and cohorts

  • Loma Linda University Health professions students or graduates

    Loma Linda University Health professions students or graduates who completed the NCT#:06229262

06

What researchers measure

Primary outcomes

  1. Fruit intake

    Fruit intake based on 24-hour dietary recall and interview

    Time frame: As reported at baseline of the NCT#:06229262 study.

  2. Vegetable intake

    Vegetable intake based on 24-hour dietary recall data

    Time frame: As reported over the 12-week duration of the NCT#:06229262 study

  3. Self-reported barriers

    Self-reported barriers to fruit and vegetable intake

    Time frame: From enrollment until the end of the survey (1 day)

  4. Self-reported facilitators

    Self-reported facilitators to fruit and vegetable intake

    Time frame: From enrollment until the end of the survey (1 day)

  5. Self-efficacy on Likert Scale

    Perceived self-efficacy related to fruit and vegetable intake

    Time frame: From enrollment until the end of the survey (1 day)

07

Study locations

No study locations are listed for this record.

08

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Start is estimated for Dec 2026; primary completion for Mar 2027, 3 months later.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 10, 2026: start Sep 2026 → Dec 2026, primary completion Dec 2026 → Mar 2027 and completion Mar 2027 → Dec 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 17, 2026
First posted
Sep 30, 2026
StartEst.
Dec 2026was Sep 2026
Primary completionEst.
Mar 2027was Dec 2026
CompletionEst.
Dec 31, 2027was Mar 2027
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Sep 23, 2026→Dec 2026
Nov 10, 2026
Primary completion
Dec 31, 2026→Mar 2027
Nov 10, 2026
Study completion
Mar 31, 2027→Dec 31, 2027
Nov 10, 2026
Registered
First appeared on the registry
Sep 30, 2026
Show all 2 updates
  1. Nov 10, 2026
    Start date Sep 23, 2026→Dec 2026
    Primary completion Dec 31, 2026→Mar 2027
    Study completion Mar 31, 2027→Dec 31, 2027
    + 2 other changes: verification date and responsible party
  2. Sep 30, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07848958
Responsible party
Sponsor
First posted
Sep 30, 2026
Start date
Dec 2026 (estimated)
Primary completion
Mar 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Nov 10, 2026

Study contacts

Amandeep Wright, MPH
Contact
amawright@llu.edu
909-558-4300 ext. 47169
Celine Heskey, DrPH
Contact
cheskey@llu.edu
909-558-1000 ext. 47181
Celine Heskey, DrPH
principal investigator · Loma Linda University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion